メインコンテンツに移動

The race to replicate

Hedge fund replication indexes were hailed as an effective means of obtaining exposure to hedge fund beta at a fraction of the cost. But how did the unproven indexes perform in the turmoil of August? By Peter Madigan

risk-1207-18-gif

Hedge fund replication indexes have experienced a baptism of fire over the past few months. The relatively new products, most of which only began trading in the first half of this year, found themselves thrust into the worst period of market volatility since the near-collapse of Long-Term Capital Management in 1998.

Replication products are designed to match the beta returns of actively managed

コンテンツを印刷またはコピーできるのは、有料の購読契約を結んでいるユーザー、または法人購読契約の一員であるユーザーのみです。

これらのオプションやその他の購読特典を利用するには、info@risk.net にお問い合わせいただくか、こちらの購読オプションをご覧ください: http://subscriptions.risk.net/subscribe

現在、このコンテンツをコピーすることはできません。詳しくはinfo@risk.netまでお問い合わせください。

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

無料メンバーシップの内容をお知りになりたいですか?ここをクリック

パスワードを表示
パスワードを非表示にする

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

ログイン
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here